Neither Grail nor Fail-In Defense of Myocardial Cell Therapy: Reply

Ann Thorac Surg. 2020 Dec;110(6):2104-2105. doi: 10.1016/j.athoracsur.2020.04.061. Epub 2020 Jun 3.

Author

Keith A Horvath¹

Affiliation

¹ Cardiothoracic Surgery Research Program, National Heart, Lung and Blood Institute, National Institutes of Health, 655 K St, NW #100, Washington, DC 20001. Electronic address: [email protected].

PMID: 32504595
DOI: 10.1016/j.athoracsur.2020.04.061

No abstract available

Publication types

Letter
Comment

MeSH terms

Bone Marrow Cells
Cell Proliferation
Cell- and Tissue-Based Therapy*
Humans
Myocytes, Cardiac*
Patients